articleTop 1% cited

The C-Reactive Protein/Albumin Ratio, a Novel Inflammation-Based Prognostic Score, Predicts Outcomes in Patients with Hepatocellular Carcinoma

Annals of Surgical Oncology · 2014 · Vol. 22(3) · pp. 803–810

Akiyoshi Kinoshita✉(The Jikei University Hospital)Hiroshi Onoda(The Jikei University Hospital)Nami Imai(The Jikei University Hospital)Akira Iwaku(The Jikei University Hospital)Mutumi Oishi(The Jikei University Hospital)Ken Tanaka(The Jikei University Hospital)Nao Fushiya(The Jikei University Hospital)Kazuhiko Koike(The Jikei University Hospital)Hirokazu Nishino(The Jikei University Hospital)Masato Matsushima(Jikei University School of Medicine)

View via DOI Publisher page

Inflammatory Biomarkers in Disease Prognosis Cancer, Lipids, and Metabolism Venous Thromboembolism Diagnosis and ManagementMedicineInternal medicineHepatocellular carcinomaHazard ratioNeutrophil to lymphocyte ratioC-reactive proteinGastroenterologySurgical oncologyMultivariate analysisProportional hazards model

MeSH terms

AdultAgedAged, 80 and overAlbuminsC-Reactive ProteinFemaleFollow-Up StudiesCarcinoma, HepatocellularHumansInflammationLiver NeoplasmsMaleMiddle AgedNeoplasm StagingPrognosis

Citations

435

FWCI

11.78

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

References

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study